A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens

Author(s):

Sven Kratochvil, Paul F. McKay, Jakub T. Kopycinski, Cynthia Bishop, Peter John Hayes, Luke Muir, Christopher L. Pinder, Deniz Cizmeci, Deborah King, Yoann Aldon, Bruce D. Wines, P. Mark Hogarth, Amy W. Chung, Stephen J. Kent, Kathrin Held, Christof Geldmacher, Len Dally, Nelson S. Santos, Tom Cole, Jill Gilmour, Sarah Fidler, Robin J. Shattock

Details:

Frontiers in Immunology, Volume 8, Issue MAY, 2017-05-24, Article number 595

Article Link: Click here

Affiliations:

• University of Oxford
• Imperial College London
• University of Melbourne
• Monash University
• Klinikum der Universität München
• Guy's Hospital
• Wellcome Trust
• Department of Microbiology & Immunology
• Burnet Institute
• The EMMES Corporation
• IAVI